---
title: "Venkat Pharma Ltd (532093) — Share Price, Financials & Analysis"
symbol: "532093"
company: "Venkat Pharma Ltd"
canonical: "https://tapetide.com/stocks/532093"
isin: "INE346F01018"
bse_code: "532093"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T20:37:52.237Z"
---

# Venkat Pharma Ltd (532093)

Canonical page: https://tapetide.com/stocks/532093

## Company

- **BSE Code:** 532093
- **ISIN:** INE346F01018
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2006-03-01
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** venkatpharmaltd.com

## About

Venkat Pharma Ltd is engaged in the manufacture and sale of finished dosages of pharmaceutical products in India.

## Latest Price

## Key Insights

### Strengths

- Stock is trading at 0.34 times its book value

### Weaknesses

- Company has low interest coverage ratio.
- Company might be capitalizing the interest cost

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 33% | 23% | 15% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.01 | 0 | 0.01 | 0 | 0 | 0.01 | 0.01 | 0 |
| Operating Profit | -0.01 | 0 | -0.01 | 0 | 0 | -0.01 | -0.01 | 0 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | -0.01 | 0 | -0.01 | 0 | 0 | -0.01 | -0.01 | 0 |
| Tax % | 0 | — | 0 | — | — | 0 | 0 | — |
| Net Profit | -0.01 | 0 | -0.01 | -0.01 | 0 | -0.01 | -0.01 | 0 |
| EPS in Rs | -0.02 | 0 | -0.02 | -0.02 | 0 | -0.02 | -0.02 | 0 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2006 15m | Mar 2007 9m | Mar 2008 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 13.84 | 0.63 | 1.05 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 12.56 | 6.92 | 2.39 | 0.2 | 0.04 | 0.02 | 0.03 | 0.02 |
| Operating Profit | 1.28 | -6.29 | -1.34 | -0.2 | -0.04 | -0.02 | -0.03 | -0.02 |
| OPM % | 9.25 | -998.41 | -127.62 | — | — | — | — | — |
| Other Income | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 |
| Interest | 2.03 | 0.25 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.28 | 0.13 | 0.06 | 0.04 | 0.02 | 0.02 | 0.02 | 0 |
| Profit before tax | -1.03 | -6.67 | -1.39 | -0.24 | -0.06 | -0.04 | -0.05 | -0.02 |
| Tax % | -5.83 | 0.15 | 0 | 4.17 | 0 | 0 | 0 | — |
| Net Profit | -0.97 | -6.68 | -1.39 | -0.25 | -0.06 | -0.04 | -0.04 | -0.02 |
| EPS in Rs | -1.94 | -13.39 | -2.79 | -0.5 | -0.12 | -0.08 | -0.08 | -0.04 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2006 | Mar 2007 | Mar 2008 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 |
| Reserves | 1.4 | -5.28 | -6.67 | -7.38 | -7.44 | -7.48 | -7.53 |
| Borrowings | 15.63 | 16.2 | 16.19 | 16.19 | 16.19 | 19.2 | 19.22 |
| Other Liabilities | 7.66 | 4.48 | 4.67 | 4.47 | 4.39 | 1.42 | 1.31 |
| Total Liabilities | 29.68 | 20.39 | 19.18 | 18.27 | 18.13 | 18.13 | 17.99 |
| Fixed Assets | 1.21 | 1.08 | 1 | 0.92 | 0.89 | 0.87 | 0.85 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 28.47 | 19.31 | 18.18 | 17.35 | 17.24 | 17.26 | 17.14 |
| Total Assets | 29.68 | 20.39 | 19.18 | 18.27 | 18.13 | 18.13 | 17.99 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2006 | Mar 2007 | Mar 2008 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | — | — | — | 0 | 0 | -0.01 | 0 |
| Cash from Investing Activity | — | — | — | 0 | 0 | 0 | 0 |
| Cash from Financing Activity | — | — | — | 0 | 0 | 0 | 0 |
| Net Cash Flow | — | — | — | 0 | 0 | -0.01 | 0 |
| Free Cash Flow | — | — | — | 0 | 0 | -0.01 | 0 |
| CFO/OP | — | — | — | 0 | 0 | 50 | 0 |

### Ratios

| Item | Jun 2006 | Mar 2007 | Mar 2008 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 482.89 | 8632.54 | 4599 | — | — | — | — |
| Inventory Days | 181.06 | 394.02 | 890.44 | — | — | — | — |
| Days Payable | 182.29 | 652.11 | 1776.87 | — | — | — | — |
| Cash Conversion Cycle | 481.65 | 8374.44 | 3712.57 | — | — | — | — |
| Working Capital Days | 539.59 | 8487.7 | 4672 | — | — | — | — |
| ROCE % | — | — | -9.14 | — | -0.44 | -0.26 | -0.3 |

## Shareholding Pattern

### annual

| Category | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 27.38% | 27.79% | 27.03% | 27.24% | 27.11% |
| FIIs | 4.49% | 3.39% | 3.34% | 3.55% | 4.17% |
| DIIs | 28.64% | 18.49% | 15.37% | 14.26% | 13.85% |
| Public | 39.49% | 50.33% | 54.27% | 54.94% | 54.86% |
| No. of Shareholders | 71445 | 67116 | 56458 | 53559 | 52380 |

### Quarterly

| Category | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 27.79% | 27.79% | 27.79% | 27.03% | 27.03% | 27.17% | 27.17% | 27.24% | 27.24% | 27.11% | 27.11% | 27.11% |
| FIIs | 3.39% | 5.69% | 3.68% | 3.44% | 3.34% | 3.33% | 3.63% | 4.04% | 3.55% | 3.4% | 3.66% | 4.17% |
| DIIs | 18.49% | 19.77% | 18.73% | 16.59% | 15.37% | 15.26% | 15.86% | 14.46% | 14.26% | 14.24% | 14.96% | 13.85% |
| Public | 50.33% | 46.74% | 49.79% | 52.94% | 54.27% | 54.23% | 53.34% | 54.27% | 54.94% | 55.25% | 54.27% | 54.86% |
| No. of Shareholders | 67116 | 62257 | 60665 | 57232 | 56458 | 55914 | 53519 | 52799 | 53559 | 54262 | 52117 | 52380 |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 7 Feb - Newspaper Publication related to Financials Results for quarter and nine months ended December 31, 2025. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 7 Feb - Newspaper Publication related to Financials Results for quarter and nine months ended December 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e9d49342-7b6c-424b-a3dc-69c461bdbfa3.pdf) |
| 6 Feb - Audio recording posted for earnings call on Feb 6, 2026 for quarter and nine months ended Dec 31, 2025. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 6 Feb - Audio recording posted for earnings call on Feb 6, 2026 for quarter and nine months ended Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/044fb721-d9c8-45dc-ad07-7a994e416e68.pdf) |
| 5 Feb - Investor Presentation for quarter and nine months ended December 31, 2025. | [Announcement under Regulation 30 (LODR)-Investor Presentation 5 Feb - Investor Presentation for quarter and nine months ended December 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/40b60ad2-8d87-4741-af34-e83d5d3b4986.pdf) |
| 26 Feb - -Analyst / Institutional Investor Meeting scheduled on February 27, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 26 Feb - -Analyst / Institutional Investor Meeting scheduled on February 27, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1fec76a5-4d63-43c0-a4bd-52ae072e9a3e.pdf) |
| 23 Feb - Allotment of 43,000 NCDs totaling INR430 crore to ADB; 7.79% coupon; 7-year tenure (23-Feb-2026 to 23-Feb-2033). | [Announcement under Regulation 30 (LODR)-Allotment 23 Feb - Allotment of 43,000 NCDs totaling INR430 crore to ADB; 7.79% coupon; 7-year tenure (23-Feb-2026 to 23-Feb-2033).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/78fe952c-7231-4957-a87d-22b58a294cec.pdf) |
| 22 Feb - Re-appointment of Rajendra Mutha as Executive Chairman from April 26, 2026 to April 25, 2031 (subject to shareholder approval). | [Update Of Meeting Held On February 22, 2026. 22 Feb - Re-appointment of Rajendra Mutha as Executive Chairman from April 26, 2026 to April 25, 2031 (subject to shareholder approval).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6bb541e3-90cf-4c04-996d-96163ad6ab63.pdf) |
| 22 Feb - Rajendra Mutha re-appointed Executive Chairman for five years from April 26, 2026 to April 25, 2031, subject to postal ballot. | [Announcement under Regulation 30 (LODR)-Change in Directorate 22 Feb - Rajendra Mutha re-appointed Executive Chairman for five years from April 26, 2026 to April 25, 2031, subject to postal ballot.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/de8648cc-c813-41fd-af88-06a90c51cef1.pdf) |
| 11 Feb - Transcript of Earning call held on February 06, 2026 at 12:30 Hrs. (IST). | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 11 Feb - Transcript of Earning call held on February 06, 2026 at 12:30 Hrs. (IST).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a915bfc7-2ac9-46bd-a7a1-a86398d31b23.pdf) |
| 10 Feb - -Analyst / Institutional Investor Meeting scheduled to be held on February 13, 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 10 Feb - -Analyst / Institutional Investor Meeting scheduled to be held on February 13, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b45c46b5-86ae-4451-be8c-cbc64011fa98.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9ab80d83-b88a-43f2-a0df-93091b79aa75.pdf) |
| Oct 2021 | [Concall - Oct 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/485d1bdc-04aa-40ee-91c3-6d3f40542407.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/37ca3b1f-9287-4f0e-8e80-a57ec28ce687.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/24150849-d294-4557-aebc-4d8c6b131d8d.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c53f9a17-f58f-4b17-a95f-33cac3baad06.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bbc21c51-89c6-4501-90ad-2292cf842db5.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7daaacc3-8e25-4f63-813a-7c1a7f1cf48d.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/742ad08f-6a1b-404f-bfb9-5d636957a73d.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d8991f71-8989-44d2-a2b2-dec1e8f0da10.pdf) |
| Mar 2022 | [Concall - Mar 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/58e0fcff-17c1-418f-a517-b662a3b120e3.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2022 from nse](https://archives.nseindia.com/annual_reports/AR_21426_KRSNAA_2021_2022_05092022220423_09062022070007.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1bab54d8-db18-459d-aefe-65c000430fef.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fe8887cd-b0fd-4e4f-bd93-af64f3b9df16.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ac2c0d26-1cb4-4f84-8208-2444482afad6.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/543328/76093543328.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T20:37:52.237Z.